 SAN DIEGO, May 14, 2021 PRNewswire -- Regulus Therapeutics Inc. Nasdaq: RGLS, a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs Regulus, today announced that Jay Hagan, President and Chief Executive Officer of Regulus, will present at the Oppenheimer Rare Orphan Disease Summit on Friday, May 21, 2021 at 11:35 A.M. ET. A live webcast of the presentation will be available on the investor relations section of the Companys website at 